WuXi Biologics (Cayman) Inc.
WXIBF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $4,834 | $3,400 | $4,420 | $3,993 |
| Dep. & Amort. | $1,437 | $1,169 | $801 | $482 |
| Deferred Tax | $0 | $0 | $0 | -$567 |
| Stock-Based Comp. | $1,216 | $1,274 | $1,297 | $532 |
| Change in WC | -$801 | -$896 | -$974 | -$963 |
| Other Non-Cash | -$1,469 | -$279 | -$2 | -$45 |
| Operating Cash Flow | $5,217 | $4,668 | $5,542 | $3,431 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$3,930 | -$4,046 | -$5,868 | -$6,523 |
| Net Acquisitions | $0 | $0 | -$131 | -$2,535 |
| Inv. Purchases | -$11,429 | -$15,083 | -$10,771 | -$59,300 |
| Inv. Sales/Matur. | $10,893 | $15,638 | $10,485 | $58,244 |
| Other Inv. Act. | $524 | $262 | $378 | $513 |
| Investing Cash Flow | -$3,942 | -$3,228 | -$5,908 | -$9,602 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $490 | -$818 | -$295 | -$147 |
| Stock Issued | $19 | $26 | $36 | $11,035 |
| Stock Repurch. | -$1,766 | -$917 | -$2,804 | -$2,517 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$1,494 | $3,670 | $472 | -$162 |
| Financing Cash Flow | -$2,750 | $1,961 | -$2,592 | $8,209 |
| Forex Effect | $84 | -$126 | $350 | -$132 |
| Net Chg. in Cash | -$1,391 | $3,275 | -$2,608 | $1,908 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $9,670 | $6,395 | $9,003 | $7,096 |
| End Cash | $8,279 | $9,670 | $6,395 | $9,003 |
| Free Cash Flow | $1,288 | $437 | -$327 | -$3,092 |